JLE

European Cytokine Network

MENU

Interferon-beta (INF-b) antibodies in interferon-b1a- and interferon-b1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-b immunogenicity in vivo. Volume 12, issue 1, March 2001

Export citation

Citation of this article, in the « Vancouver » format:

P. Perini, A. Facchinetti, P. Bulian, A.R. Massaro, D. De Pascalis, A. Bertolotto, G. Biasi, P. Gallo. Interferon-beta (INF-b) antibodies in interferon-b1a- and interferon-b1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-b immunogenicity in vivo.. European Cytokine Network. 2001;12(1):56-61.

Download (RIS) Add to my bibliography

The citations in my bibliography.